The recent FDA accelerated approval of lifileucel, known commercially as Amtagvi, marks a groundbreaking development in cancer therapy. This treatment is the first of its kind, a tumor-derived autologous T cell immunotherapy, specifically targeting patients with unresectable or metastatic melanoma who have undergone prior treatments. This
Read More
As we navigate the chilly months of winter, we’re not just braving the cold but also a variety of respiratory illnesses, including COVID-19. Recent trends indicate a slight decrease in COVID-19 cases. For instance, hospital admissions have dropped from around 35,000 per week to approximately 20,000,
Read MoreClear Health Pass™ LLC acts as Authorized Representative of tribal, federally chartered corporations formed under Section 17 of the Indian Reorganization Act (IRA), U.S.C. Title 25.
(800) 266-7207
(212) 313-9529
© 2023 Clear Health Pass Holdings™, LLC., All trademark references are trademarks of either the Clear Health Pass Holdings, LLC or their respective owners.